ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.

GOLDEN, Colo., July 21, 2021 /PRNewswire/ — ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device “ArcScan Insight® 100, ” headquartered in Golden, Colorado, ...

ArcScan Announces Sale of Insight® 100 Device for Ophthalmic Imaging to Walter Reed Medical Center and Naval Hospital Camp LeJeuneArcScan Announces Sale of Insight® 100 Device for Ophthalmic Imaging to Walter Reed Medical Center and Naval Hospital Camp LeJeune

ArcScan, Inc., developer of state-of-the-art ophthalmic imaging technology, announced today that the company has closed sales for its Insight® 100 ...